| Financial Year |
March 31 2023 |
| Monetary Funds |
3,398,271,479.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
252,682,669.64 |
| Accounts Receivable |
2,650,684,033.11 |
| Advances to Suppliers |
483,243,280.63 |
| Other Receivables |
50,989,357.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,179,878.14 |
| Inventories |
2,258,216,875.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
117,434,957.76 |
| Total Current Assets |
10,812,347,259.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
262,832,677.35 |
| Investment Properties |
303,578,791.48 |
| Fixed Assetes |
929,652,526.92 |
| Under-construction Projects |
14,522,682.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
713,493,516.17 |
| R&D expenses |
758,569,849.10 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,354,886.51 |
| Deferred Income Tax Assets |
102,265,887.37 |
| Other Non-Current Assets |
52,081,491.71 |
| Sub-Total of Non-Current Assets |
3,463,839,575.28 |
| Total Assets |
14,276,186,834.54 |
| Short-Term Loans |
215,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
504,980,184.81 |
| Accounts Payable |
3,631,264,745.04 |
| Accounts Received In Advance |
4,139,585.86 |
| Employee Compensation Payable |
25,548,502.21 |
| Taxes Payable |
32,635,533.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,283,038.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
110,023,500.01 |
| Other Current Liabilities |
51,161,868.83 |
| Sub-Total of Current Liabilities |
5,640,023,200.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
59,949,344.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
422,689,592.60 |
| Total Liabilities |
6,062,712,793.45 |
| Paid-In Capital(Or Share Stock) |
1,182,489,135.00 |
| Capital Surplus |
1,718,514,311.95 |
| Surplus Reserve |
192,881,344.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,199,095,046.48 |
| Minority Stockholder's Interest |
1,903,972,249.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,309,501,791.11 |
| Owner's Equity（Stockholder's Equity） |
8,213,474,041.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,276,186,834.54 |
